ProCE Banner Series

Exploring the Endometrial Cancer Landscape: An Expert’s Roadmap to Expanding Indications, Emerging Challenges, and Equity Considerations

Live and encore webinar presentation with live Q&A with a panel of experts covering the clinical landscape for endometrial cancer, including key data from the 2025 SGO annual meeting to help inform your gynecologic cancers clinical practice.

  AMA
Who Should Attend

This educational activity is intended for medical oncologists, gynecologic oncologists, and other healthcare professionals who treat patients with endometrial cancer.

All Events

Exploring the Endometrial Cancer Landscape: An Expert’s Roadmap to Expanding Indications, Emerging Challenges, and Equity Considerations

Upcoming Events

April

11

2025

3:00 PM - 4:30 PM Central Time (CT)

Virtual

April

25

2025

2:30 PM - 4:00 PM Central Time (CT)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in the treatment of patients with endometrial cancer.

Target Audience
This educational activity is intended for medical oncologists, gynecologic oncologists, and other healthcare professionals who treat patients with endometrial cancer.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify patients with endometrial cancer at elevated risk for adverse outcomes based on demographic factors such as race, ethnicity, gender identity, and socioeconomic status

  • Counsel patients on the molecular biology and rationale for precision approaches to treatment of advanced endometrial cancer

  • Perform molecular testing to guide optimal treatment selection for patients with advanced endometrial cancer

  • Synthesize approvals, clinical data, guidelines, and patient factors to individualize treatment of patients with advanced endometrial cancer

Accreditation

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by an educational grants from Eisai, GlaxoSmithKline, and Merck Sharp & Dohme LLC.
 

 

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191